Hiroo Ohnishi

1.7k total citations
49 papers, 1.3k citations indexed

About

Hiroo Ohnishi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Hiroo Ohnishi has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 29 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Hiroo Ohnishi's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (13 papers) and Hepatitis C virus research (10 papers). Hiroo Ohnishi is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (13 papers) and Hepatitis C virus research (10 papers). Hiroo Ohnishi collaborates with scholars based in Japan, United States and Germany. Hiroo Ohnishi's co-authors include Yasutoshi Muto, Hisataka Moriwaki, Yoshihide Ishiki, Toshikazu Nakamura, Kunio Matsumoto, Masahito Nagaki, Masahiko Kato, Masahiro Tajika, Tomohiro Kato and Yoshiyuki Miwa and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Virology.

In The Last Decade

Hiroo Ohnishi

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroo Ohnishi Japan 19 844 675 307 198 190 49 1.3k
Gert Judmaier Austria 11 577 0.7× 574 0.9× 146 0.5× 115 0.6× 146 0.8× 11 1.1k
Hartwig Bunzendahl United States 23 958 1.1× 632 0.9× 769 2.5× 85 0.4× 305 1.6× 38 1.8k
B Kommerell Germany 25 580 0.7× 679 1.0× 340 1.1× 121 0.6× 357 1.9× 126 1.8k
Yedidya Saiman United States 14 798 0.9× 767 1.1× 209 0.7× 180 0.9× 282 1.5× 22 1.4k
I G McFarlane United Kingdom 22 937 1.1× 793 1.2× 180 0.6× 139 0.7× 126 0.7× 43 1.4k
Alişan Kahraman Germany 19 545 0.6× 900 1.3× 300 1.0× 162 0.8× 294 1.5× 62 1.4k
Qinghua Meng China 19 605 0.7× 734 1.1× 136 0.4× 149 0.8× 334 1.8× 70 1.4k
Ludger Leifeld Germany 26 824 1.0× 810 1.2× 477 1.6× 528 2.7× 227 1.2× 73 2.1k
A. Caligiuri Italy 8 815 1.0× 613 0.9× 423 1.4× 58 0.3× 182 1.0× 26 1.3k
Hiroki Sakaguchi Japan 18 742 0.9× 1.1k 1.6× 223 0.7× 77 0.4× 264 1.4× 77 1.5k

Countries citing papers authored by Hiroo Ohnishi

Since Specialization
Citations

This map shows the geographic impact of Hiroo Ohnishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroo Ohnishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroo Ohnishi more than expected).

Fields of papers citing papers by Hiroo Ohnishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroo Ohnishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroo Ohnishi. The network helps show where Hiroo Ohnishi may publish in the future.

Co-authorship network of co-authors of Hiroo Ohnishi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroo Ohnishi. A scholar is included among the top collaborators of Hiroo Ohnishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroo Ohnishi. Hiroo Ohnishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohnishi, Hiroo, et al.. (2018). Acute-on-Chronic Liver Failure. PubMed. 217–9. 13 indexed citations
3.
Furusyo, Norihiro, Eiichi Ogawa, Masayuki Murata, et al.. (2013). Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response. Journal of Antimicrobial Chemotherapy. 69(2). 483–490. 13 indexed citations
4.
Nagaki, Masahito, et al.. (2005). Effects of plasma from patients with fulminant hepatic failure on function of primary rat hepatocytes in three‐dimensional culture. Liver International. 25(5). 1010–1017. 5 indexed citations
5.
Nagaki, Masahito, Taku Naiki, Kiminori Kimura, et al.. (2005). Prospective study on early virologic response to treatment with interferon α-2b plus ribavirin in patients with chronic hepatitis C genotype 1b. Hepatology Research. 33(4). 285–291. 12 indexed citations
6.
Yamada, Yasuhiro, Masataka Okuno, Hiroo Ohnishi, et al.. (2005). Liver injury induced by lipopolysaccharide is mediated by TNFR-1 but not by TNFR-2 or Fas in mice. Hepatology Research. 31(3). 136–142. 23 indexed citations
7.
Fukutomi, Yasushi, Masahiro Tajika, Kenji Yamazaki, et al.. (2004). A CASE OF ULCERATIVE COLITIS ASSOCIATED WITH SEPSIS AND INTRA VERTEBRAL CANAL ABSCESS INDUCED BY ORAL ADMINISTRATION OF POLYETHYLENE GLYCOL ELECTROLYTE LAVAGE SOLUTION. Acta gastro-enterologica belgica. 46(6). 1181–1185. 2 indexed citations
8.
Kasahara, Senji, Takeshi Hara, Hiroyasu Itoh, et al.. (2002). Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor. British Journal of Haematology. 118(1). 181–188. 15 indexed citations
10.
11.
Kimura, Kiminori, Kazuki Ando, Hiroo Ohnishi, et al.. (1999). Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. International Immunology. 11(9). 1491–1500. 45 indexed citations
12.
Ando, Kazuki, Kiminori Kimura, Hiroo Ohnishi, et al.. (1999). IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. International Immunology. 11(5). 657–665. 28 indexed citations
13.
Kajiwara, Kenta, Masataka Okuno, Tetsuo Kobayashi, et al.. (1998). Oral Supplementation with Branched-Chain Amino Acids Improves Survival Rate of Rats with Carbon Tetrachloride-Induced Liver Cirrhosis. Digestive Diseases and Sciences. 43(7). 1572–1579. 41 indexed citations
14.
Ohnishi, Hiroo, et al.. (1996). Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. Digestive Diseases and Sciences. 41(7). 1487–1493. 36 indexed citations
15.
Moriwaki, Hisataka, Nobuo Murakami, Mitsuru Seishima, et al.. (1993). The Clearance Rate of Chylomicron Retinyl Ester from Plasma Can Be Used to Distinguish Rats with Cirrhosis from Those with Portacaval Shunt. Hepatology. 17(1). 125–130. 4 indexed citations
17.
Muraiso, Kanae, Makoto Hijikata, Nobuo Okazaki, et al.. (1991). Detection of Hepatitis C Virus Infection by Enzyme‐linked Immunosorbent Assay System Using Core Protein Expressed in Escherichia coli. Japanese Journal of Cancer Research. 82(8). 879–882. 9 indexed citations
18.
Muto, Yasutoshi, Junichi Sugihara, Hiroo Ohnishi, Hisataka Moriwaki, & Kusuya Nishioka. (1990). Anti-hepatitis C virus antibody prevails in fulminant hepatic failure. Gastroenterologia Japonica. 25(1). 32–35. 26 indexed citations
19.
Ohnishi, Hiroo, Hisataka Moriwaki, Kazuo Nagura, et al.. (1989). Experimental studies on the pathogenesis of fulminant hepatitis with respect to tumor necrosis factor(TNF).. Kanzo. 30(1). 103–104. 4 indexed citations
20.
Hayashi, Masanori, et al.. (1981). Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication. Gastroenterologia Japonica. 16(1). 64–70. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026